Table II.
Variable | No. patients (n) | Mean ± SD | Range | Subgroup (n) | Mean ± SD |
---|---|---|---|---|---|
1st IVF cycle | |||||
Duration of rFSH administration (days) | 40 | 11.4±1.25 | 9-13 | A1 (10) | 11.4±1.26 |
A2 (10) | 11.2±1.39 | ||||
B1 (10) | 11.5±1.43 | ||||
B2 (10) | 11.4±1.07 | ||||
Total dose of rFSH administered (IU) | 40 | 3,875.0±702.85 | 2,475-5,200 | A1 (10) | 3,922.5±649.62 |
A2 (10) | 3,830.0±750.53 | ||||
B1 (10) | 3,895.0±858.03 | ||||
B2 (10) | 3,852.5±644.96 | ||||
2nd IVF cycle | |||||
Duration of rFSH administration (days) | 35 | 10.6±1.19 | 9-13 | A1 (8) | 10.5±1.19 |
A2 (8) | 10.5±1.19 | ||||
B1 (10) | 10.9±1.29 | ||||
B2 (9) | 10.5±1.24 | ||||
Total dose of rFSH administered (IU) | 35 | 3,652.1±538.80 | 2,700–4,875 | A1 (8) | 3,650.0±662.92 |
A2 (8) | 3,681.2±514.04 | ||||
B1 (10) | 3,700.0±560.88 | ||||
B2 (9) | 3,575.0±503.74 |
No significant differences were identified. rFSH, recombinant follicle stimulating hormone; IVF, in vitro fertilisation; SD, standard deviation.